重组性脑衍生神经营养因子生产的挑战
Éllen F Rodrigues1, Ana L Fachin2, Mozart Marins3
1Biotechnology Unit, University of Ribeirão Preto/UNAERP, Ribeirão Preto, SP, Brazil.
Trends in biotechnology
|November 26, 2023
概括
制造生物活性大脑衍生神经营养因子 (BDNF) 用于制药是具有挑战性的,因为它的结构完整性. 高效的工业生产需要一个精心选择的表达系统,以确保稳定性和有效性.
科学领域:
- 神经科学是一个神经科学.
- 生物技术是生物技术.
- 制药科学 制药科学
背景情况:
- 脑衍生神经营养因子 (BDNF) 是一种具有重要商业和治疗潜力的关键神经营养因子.
- 维护BDNF的结构完整性,特别是囊结,在其大规模生产中是一个主要障碍.
研究的目的:
- 突出表达系统在BDNF的工业生产中的重要性.
- 为解决制造稳定和生物活性BDNF用于制药应用的挑战.
主要方法:
- 这项研究重点关注表达系统在克服生产挑战方面的关键作用.
- 它强调需要系统来保护BDNF的结构完整性.
主要成果:
- 选择合适的表达系统对于有效的BDNF生产至关重要.
- 成功的生产取决于维持神经质蛋白的生物活性和稳定形式.
结论:
- 适合的表达系统对于工业规模制造药品级BDNF至关重要.
- 解决结构性保存挑战将使BDNF的治疗用途成为可能.
更多相关视频
相关概念视频
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


